Swaap Raises $4.5 Seed Round
Apr 2023
We are proud to lead this round alongside other great investors such as New Form Capital, C² Ventures, Kima Ventures, Pareto Ventures, Entrepreneur First, and more.
ReadCelestia raises $55M!
Oct 2022
The Celestia Foundation has raised $55 million in support from rounds led by Bain Capital Crypto and Polychain Capital with participation from Placeholder, Galaxy, Delphi Digital, Blockchain Capital, NFX, Protocol Labs, Figment, Maven 11, Spartan Group, Jump Crypto, and select angels.
ReadValory: Enabling rich dApps through an open and permissionless agent protocol
Oct 2022
We are excited to back Valory in their mission to bring rich applications to web3 by building the open and autonomous service layer.
ReadFrontdoor Labs Raises $1M Pre-Seed Round Led by Signature Ventures
Oct 2022
We are truly excited to lead Frontdoor Labs' $1 million seed round and back the team on its mission to build a global web3 talent network.
ReadValory Closes $4M Seed Round
Oct 2022
We are thrilled to back Valory on their mission to solve some of the greatest challenges in web3, as part of their $4M Seed round led by True Ventures.
ReadNevermined Closes €3M Seed Round
Jul 2022
We are thrilled to co-lead Nevermined's €3 million seed round together with our friends at Polymorphic Capital.
ReadMolecule Raises $13M Seed!
Jun 2022
We are proud to have been there from the start and to be part of the amazing journey building the future of decentralized science.
ReadNotabene Raises $10.2M Series A!
Nov 2021
We are proud to have been there from the start and are happy to continue backing their outstanding team through our follow-on investment in this Series A.
ReadBTP Closes £2M Seed Round
Jul 2021
We are thrilled to be a major part of the £2M seed round of Blockchain Technology Partners led by Force Over Mass and us.
ReadBTP: Simplifying the Deployment and Management of Enterprise Blockchain Infrastructure
Jul 2021
We are excited to back BTP’s enterprise blockchain experts on their mission to bring the benefits of distributed ledgers to businesses.
ReadUnchained Raises $25M Series A
Jun 2021
Our portfolio company Unchained has closed a $25M Series A, bringing its company valuation to $125M.
ReadFinoa Closes $22M Series A
Apr 2021
We are thrilled to announce that we continue to back our portfolio company Finoa as part of their Series A round led by Balderton Capital.
ReadCelestia: The General-Purpose Data Availability Layer of the Decentralized Internet
Mar 2021
Read our Investment Thesis on why Celestia and its general-purpose data availability layer is a paradigm shift for scalable Blockchain architecture and a catalyst towards a decentralized Internet.
ReadCelestia Closes $1.5M Seed Round
Mar 2021
We are thrilled to be a major part of the $1.5M seed round of Celestia alongside Binance Labs, Maven11 and KR1.
ReadUnchained Raises $5.5M Seed Round
Mar 2021
Unchained raised a $5.5 million equity seed round led by institutional Bitcoin technology and financial services firm NYDIG.
ReadUnchained: Unlocking the Potential of Bitcoin-Native Multisignature Capabilities
Dec 2020
Unchained provides financial services on top of its highly secure and innovative collaborative custody infrastructure tailored to the needs of long-term Bitcoin holders.
ReadNotabene: Embracing Regulation within the Blockchain Space
Nov 2020
Notabene is building a Blockchain-focused compliance platform to provide crypto businesses with the tools to implement regulatory compliance in a simple way. Their diverse founder team follows a Blockchain-first approach combining decentralized-identity technology with the highest compliance standards.
ReadNotabene Raises Seed Round of $1.77M
Nov 2020
As Notabene's first institutional investor in their pre-Seed stage, we are happy to be accompanied by well-known names from the Blockchain and FinTech space: our network partners at Castle Island Ventures led the Seed round, joined by Green Visor Capital, among others.
ReadMolecule: The Next Stage in the Evolution of Drug Development
Jul 2020
Molecule aims to disrupt the pharmaceutical drug discovery and development industry. Their outstanding team is building a trust-less open platform for the efficient management of pharmaceutical intellectual property (IP) between researchers and investors.
Read